prostaglandin G/H synthase gene therapy (GeneMedicine)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprostaglandin G/H synthase gene therapy (GeneMedicine)
Drug Alias Namehypertension gene therapy (GeneMedicine)respiratory distress gene therapy (GeneMedicine)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionProstaglandin modulators
TargetsProstaglandin
Therapy Area/IndicationsHypertensionRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenemedicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenemedicine Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A